The Brighterside of News on MSN
Spring daylight saving time shift linked to higher risk of retinal disease
Daylight saving time does more than alter clocks. The spring loss of one hour may also raise the risk of retinal disease, ...
A new study links spring daylight saving time changes to an up to 30% increased risk of retinal vascular disease.
Morning Overview on MSN
Ozempic-style drugs were not linked to a serious eye disease in people with diabetes
Millions of people with type 2 diabetes who take semaglutide, the active ingredient in Ozempic and Wegovy, can draw some ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Back ...
Many of the world's leading causes of irreversible blindness, including glaucoma and age-related macular degeneration, share ...
Sunir Garg, MD, expresses excitement about attending AAO 2025 and focuses on several topics to be discussed. These include the benefits and potential vision risks of GLP-1 inhibitors in patients with ...
Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...
In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Here’s what to know about the irreversible eye disease at the center of the new National Geographic documentary Blink. Retinitis pigmentosa is a rare visual disorder that affects a layer of tissue in ...
Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease type 1, having met the primary efficacy endpoint, reduction in lesion growth Presentation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results